Literature DB >> 11844290

Variable expression of long QT syndrome among gene carriers from families with five different HERG mutations.

Jesaia Benhorin1, Arthur J Moss, Matthew Bak, Wojciech Zareba, Elizabeth S Kaufman, Batsheva Kerem, Jeffrey A Towbin, Silvia Priori, Robert S Kass, Bernard Attali, Arthur M Brown, Eckhard Ficker.   

Abstract

OBJECTIVES: This study assessed the phenotypic variability of LQTS in carriers with the same and with different mutations in the LQT2 gene.
BACKGROUND: Mutations of ion-channel genes are known to cause the long QT syndrome (LQTS), a disorder associated with distinctive genotypic-specific electrocardiographic patterns and variable clinical expression.
METHODS: Clinical and electrocardiographic characteristics were assessed in five large LQTS families, each with a different mutation of the HERG gene (LQT2; n = 469, 69% genotyped, 102 carriers). One mutation was located on the N-terminus and the other four on the C-terminus of the HERG channel protein.
RESULTS: The QTc duration and the frequency of cardiac events (syncope and LQTS-related cardiac arrest/death) were similar among carriers with the five HERG mutations. QTc was as variable in carriers of the same mutation as it was among carriers with different HERG mutations (P = 0.19). Qualitative assessment of the electrocardiograms revealed extensive intra-and interfamilial variability in T-wave morphology. Among carriers with multiple electrocardiograms extending over 2 to 7 years, variation in QTc over time was minimal. A strong association was found between QTc and the occurrence of cardiac events in carriers of all five mutations.
CONCLUSIONS: The clinical expression of LQTS was equally variable in carriers from families with the same or different HERG mutations. These findings highlight the complexity of the clinical phenotype in this Mendelian dominant disorder and suggest that one or more modifier genes contribute to the variable expression of this syndrome.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11844290      PMCID: PMC7027696          DOI: 10.1111/j.1542-474x.2001.tb00137.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  21 in total

1.  Long QT syndrome: more questions.

Authors:  A J Moss
Journal:  J Cardiovasc Electrophysiol       Date:  2001-04

2.  Electrocardiographic prediction of abnormal genotype in congenital long QT syndrome: experience in 101 related family members.

Authors:  E S Kaufman; S G Priori; C Napolitano; P J Schwartz; S Iyengar; R C Elston; A H Schnell; E Z Gorodeski; G Rammohan; N O Bahhur; D Connuck; L Verrilli; D S Rosenbaum; A M Brown
Journal:  J Cardiovasc Electrophysiol       Date:  2001-04

3.  Novel missense mutation in the cyclic nucleotide-binding domain of HERG causes long QT syndrome.

Authors:  C A Satler; E P Walsh; M R Vesely; M H Plummer; G S Ginsburg; H J Jacob
Journal:  Am J Med Genet       Date:  1996-10-02

4.  MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia.

Authors:  G W Abbott; F Sesti; I Splawski; M E Buck; M H Lehmann; K W Timothy; M T Keating; S A Goldstein
Journal:  Cell       Date:  1999-04-16       Impact factor: 41.582

5.  Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias.

Authors:  P J Schwartz; S G Priori; C Spazzolini; A J Moss; G M Vincent; C Napolitano; I Denjoy; P Guicheney; G Breithardt; M T Keating; J A Towbin; A H Beggs; P Brink; A A Wilde; L Toivonen; W Zareba; J L Robinson; K W Timothy; V Corfield; D Wattanasirichaigoon; C Corbett; W Haverkamp; E Schulze-Bahr; M H Lehmann; K Schwartz; P Coumel; R Bloise
Journal:  Circulation       Date:  2001-01-02       Impact factor: 29.690

6.  Mutations in the hminK gene cause long QT syndrome and suppress IKs function.

Authors:  I Splawski; M Tristani-Firouzi; M H Lehmann; M C Sanguinetti; M T Keating
Journal:  Nat Genet       Date:  1997-11       Impact factor: 38.330

7.  Novel characteristics of a misprocessed mutant HERG channel linked to hereditary long QT syndrome.

Authors:  E Ficker; D Thomas; P C Viswanathan; A T Dennis; S G Priori; C Napolitano; M Memmi; B A Wible; E S Kaufman; S Iyengar; P J Schwartz; Y Rudy; A M Brown
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-10       Impact factor: 4.733

8.  ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome.

Authors:  A J Moss; W Zareba; J Benhorin; E H Locati; W J Hall; J L Robinson; P J Schwartz; J A Towbin; G M Vincent; M H Lehmann
Journal:  Circulation       Date:  1995-11-15       Impact factor: 29.690

9.  Influence of the genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group.

Authors:  W Zareba; A J Moss; P J Schwartz; G M Vincent; J L Robinson; S G Priori; J Benhorin; E H Locati; J A Towbin; M T Keating; M H Lehmann; W J Hall
Journal:  N Engl J Med       Date:  1998-10-01       Impact factor: 91.245

10.  SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome.

Authors:  Q Wang; J Shen; I Splawski; D Atkinson; Z Li; J L Robinson; A J Moss; J A Towbin; M T Keating
Journal:  Cell       Date:  1995-03-10       Impact factor: 41.582

View more
  12 in total

Review 1.  Defective cardiac ion channels: from mutations to clinical syndromes.

Authors:  Colleen E Clancy; Robert S Kass
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

Review 2.  The renal plumbing system: aquaporin water channels.

Authors:  L N Nejsum
Journal:  Cell Mol Life Sci       Date:  2005-08       Impact factor: 9.261

3.  Clinical, genetic, and electrophysiologic characteristics of a new PAS-domain HERG mutation (M124R) causing Long QT syndrome.

Authors:  Liat Shushi; Batsheva Kerem; Maya Goldmit; Asher Peretz; Bernard Attali; Aron Medina; Jeffrey A Towbin; Junko Kurokawa; Robert S Kass; Jesaia Benhorin
Journal:  Ann Noninvasive Electrocardiol       Date:  2005-07       Impact factor: 1.468

Review 4.  Epidemiology of sudden cardiac death: clinical and research implications.

Authors:  Sumeet S Chugh; Kyndaron Reinier; Carmen Teodorescu; Audrey Evanado; Elizabeth Kehr; Mershed Al Samara; Ronald Mariani; Karen Gunson; Jonathan Jui
Journal:  Prog Cardiovasc Dis       Date:  2008 Nov-Dec       Impact factor: 8.194

5.  Sudden cardiac death in low- and middle-income countries.

Authors:  Rajesh Vedanthan; Valentin Fuster; Avi Fischer
Journal:  Glob Heart       Date:  2012-12-05

6.  Physiological genomics identifies genetic modifiers of long QT syndrome type 2 severity.

Authors:  Sam Chai; Xiaoping Wan; Angelina Ramirez-Navarro; Paul J Tesar; Elizabeth S Kaufman; Eckhard Ficker; Alfred L George; Isabelle Deschênes
Journal:  J Clin Invest       Date:  2018-02-12       Impact factor: 14.808

Review 7.  Electromechanical heterogeneity in the heart : A key to long QT syndrome?

Authors:  F F Dressler; J Brado; K E Odening
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2017-12-12

8.  Electrophysiologic substrate in congenital Long QT syndrome: noninvasive mapping with electrocardiographic imaging (ECGI).

Authors:  Ramya Vijayakumar; Jennifer N A Silva; Kavit A Desouza; Robert L Abraham; Maria Strom; Frederic Sacher; George F Van Hare; Michel Haïssaguerre; Dan M Roden; Yoram Rudy
Journal:  Circulation       Date:  2014-10-07       Impact factor: 29.690

9.  Risk of death in the long QT syndrome when a sibling has died.

Authors:  Elizabeth S Kaufman; Scott McNitt; Arthur J Moss; Wojciech Zareba; Jennifer L Robinson; W Jackson Hall; Michael J Ackerman; Jesaia Benhorin; Emanuela T Locati; Carlo Napolitano; Silvia G Priori; Peter J Schwartz; Jeffrey A Towbin; G Michael Vincent; Li Zhang
Journal:  Heart Rhythm       Date:  2008-03-04       Impact factor: 6.343

Review 10.  Pharmacogenetic aspects of drug-induced torsade de pointes: potential tool for improving clinical drug development and prescribing.

Authors:  Rashmi R Shah
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.